In this study, we demonstrate that EGF can induce the expression of miR-21, which enhances EGF-induced pancreatic cancer cell survival by targeting the MAPK/ERK and PI3K/AKT signaling pathways. This evidence concerns the gene AKT1 and pancreatic neoplasm.